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Glutamate uptake occurs at an early stage of synaptic vesicle
recycling
Ian A. Prior and Michael J. Clague
Rapid membrane recycling in nerve terminals is
required to maintain rapid synaptic transmission.
Following the fusion of synaptic vesicles with synaptic
plasma membranes, recycling can occur via clathrin-
coated vesicles (CCVs) [1–3]. The fate of these vesicles
is uncertain: they could simply uncoat and acquire other
proteins from the cytosol to regenerate synaptic
vesicles or they may fuse with endosomal structures
from which synaptic vesicles could then bud. We have
purified both CCVs and synaptic vesicles from rat brain,
and measured the ability of these vesicle fractions to
take up the excitatory neurotransmitter glutamic acid.
We found that the normalized levels of glutamate
uptake by the two types of vesicle were very similar. For
each vesicle fraction, uptake required ATP and Cl– and
could be fully inhibited by the specific vacuolar proton
pump (v-ATPase) inhibitor concanamycin. We suggest
that this ability to refill vesicles with neurotransmitter
at the earliest intermediate on the recycling pathway —
the CCV — may allow uncoated vesicles to immediately
enter the releasable pool without sacrificing the
quantal nature of neurotransmitter release.
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Results and discussion
Nerve terminal CCVs are a distinct population of vesicles
which incorporate both the plasma-membrane-associated
AP2 adaptor protein and several markers of synaptic
vesicles [2,4]. It has been shown that CCVs prepared from
rat cortex nerve terminals contain, at the same stoichiome-
tries as purified synaptic-vesicle fractions, integral pro-
teins that are widely used marker proteins for synaptic
vesicles [2]. These proteins include the v-SNARE synap-
tobrevin, the Ca2+-sensor synaptotagmin, subunits of
v-ATPase, and an abundant protein of unknown function,
synaptophysin. These observations have been important
in establishing the recycling pathway of CCVs as a signifi-
cant route of synaptic-vesicle protein recycling. They are
also consistent with a minimal model for the recycling
pathway, in which uncoating of the first intermediate
vesicle — the CCV — can essentially generate a synaptic
vesicle without the necessity for passage through an endo-
somal intermediate. 
We have used established methods to prepare fractions of
synaptic vesicles [5] and CCVs [2], and compared the
ability of these fractions to take up glutamate, the major
neurotransmitter of the central nervous system. In order to
adjust for the large contributions of coat proteins to the
content of the CCV fraction, we have normalized the gluta-
mate uptake to the synaptophysin content of each fraction
(Fig. 1). Synaptophysin has been shown to localize specifi-
cally to the vesicles of the synaptic terminals in rat brain
[6]. Electron-microscopic observation of the CCV prepara-
tions confirmed that over 90% of observable structures
were coated, whereas the synaptic-vesicle preparation con-
tained no coated structures and predominantly comprised
small vesicles (Fig. 2). Negatively stained preparations of
synaptic vesicles and of stripped CCVs were efficiently
labelled with an anti-synaptophysin antibody coupled to
protein A–colloidal gold (data not shown). The major cont-
aminant of these fractions is known to be myelinated mem-
brane, which does not contain synaptophysin or take up
glutamate by a mechanism dependent on v-ATPase.
The measured glutamate uptake we obtained was similar
for each of the three purified vesicle fractions (Fig. 3). We
obtained similar results with CCVs prepared both from
whole brain and from synaptosomes, consistent with the
observation of Maycox et al. [2] that the stoichiometries of
vesicle markers are unchanged between these prepara-
tions. For each of the three vesicle fractions, glutamate
uptake was inhibited by the absence of ATP and Cl– (Fig.
3). For the synaptic-vesicle fraction, our measured levels of
uptake (in pmol mg–1) are comparable to values published
previously [7,8]. Loss of coat protein from the CCVs was
not observed during the incubation (data not shown). 
The driving force for uptake into synaptic vesicles is
provided by the vesicle membrane potential (∆c) gener-
ated by the v-ATPase [8]. We have used a specific inhibitor
of this pump, concanamycin, to show that uptake is com-
pletely dependent on v-ATPase activity for both CCVs and
synaptic vesicles (Fig. 3). The presence of an active v-
ATPase may be a unique feature of endocytic CCVs
derived from nerve terminals, as an endocytic CCV fraction
derived from hepatocytes was found to be incapable of
acidifying [9]. The v-ATPase is a multisubunit enzyme
which may be regulated differentially according to its
subcellular location. Although it has previously been
shown to be present in CCVs derived from nerve termi-
nals, to our knowledge, this is the first direct demonstra-
tion of its actual activity in this fraction.
Membrane recycling at the nerve terminal is fast relative
to the rates observed in nonpolarized cells. Capacitance
measurements on retinal bipolar cells of goldfish have
revealed two time constants for membrane retrieval,
depending on the duration of depolarization: 1–2 seconds
following a brief depolarization, and 20–30 seconds follow-
ing prolonged stimulation [10]. This indicates that there
may be two separate mechanisms for membrane retrieval,
with the fast phase corresponding to a ‘kiss-and-run’
model originally proposed by Ceccarelli et al. [11] in
which, after fusion of the synaptic vesicle with the plasma
membrane, the fusion pore never dilates but rather
reseals, causing the synaptic vesicle to pinch off. The
slower retrieval mechanism may correspond to recycling
by the CCV pathway following full collapse of the synap-
tic vesicle into the plasma membrane, which has been
observed in a number of morphological studies of synap-
tic-vesicle recycling [1,3], reviewed by De Camilli and
Takei [12]. The relative importance of these two path-
ways in synaptic-vesicle recycling is presently controver-
sial. Measurements of the time constants for retrieval of
exocytosed membrane in rat hippocampal neurons and at
the frog neuromuscular junction have yielded the values
20–40 and 60 seconds, respectively [13,14], consistent
with recycling via CCVs. 
The fate of CCVs after internalization is unclear. It was
originally proposed that these vesicles coalesce, or fuse
with existing endosomal structures, to form internal cister-
nae from which synaptic vesicles then bud [1]. This
notion has been supported by studies of a neuroendocrine
cell line, PC12, for which material to be incorporated into
small synaptic-like vesicles is believed to pass through an
early endosomal intermediate [15–17]. Recent morpho-
logical studies on isolated nerve terminals have suggested,
however, that the observed cisternae correspond to large
chunks of plasma membrane that have pinched off or that,
in some cases, even remain contiguous with the plasma
membrane [3]. Budding of CCVs from these cisternae was
also elegantly demonstrated [3]; the study did not com-
pletely rule out obligatory passage of material recycling
via CCVs through an endosomal intermediate, but it has
provided an alternative explanation for the key observa-
tion underpinning this idea. It now seems most likely that
uncoating of CCVs generates synaptic vesicles without
passage through a further compartment. According to this
model, certain cytosolic proteins, for example rab3A, may
have to associate with the vesicle after uncoating to confer
exocytic properties [18].
Regenerated synaptic vesicles do not go to the back of the
queue for subsequent exocytosis, but rather reincorporate
randomly into the releasable pool [19]. The time constant
for reincorporation of retrieved vesicles into the releasable
pool (the repriming time) has been measured as
30–60 seconds and 15–30 seconds in rat hippocampal
neurons and at the frog neuromuscular junction, respec-
tively [13,14]. In order to ensure quantal release of
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Figure 1
(a) Enrichment of synaptophysin during the purification of vesicle
fractions. CCVs were purified either from homogenate of whole brain
(WB CCV) or from synaptosomes (nerve terminals, NT CCV) isolated
from homogenate in a series of steps to give, consecutively, light
membranes (LM), supernatant produced following Ficoll density gradient
centrifugation (PFS), and a supernatant fraction enriched in clathrin-
coated structures (EF), which was then pelleted through a D20/8%
sucrose layer to yield CCVs. For synaptic-vesicle preparation,
synaptosomes isolated from brain homogenate were consecutively
purified to give a supernatant of synaptosomal lysate (LS1), pelleted
membranes from LS1 (LP2), and the fraction pelleted following
collection from a linear sucrose gradient loaded with LP2 (SVP). See
Materials and methods for a more detailed explanation of purification
procedures. Protein from each step (9mg) was separated by
SDS–PAGE and synaptophysin detected by western blotting. 
(b) Quantitative analysis of blots probed with [125I]Protein A was
performed in order to accurately account for synaptophysin content.
Phosphorimager analysis indicated that 65mg WB CCV, 30 mg NT CCV
and 10 mg SVP all contained equivalent amounts of synaptophysin.
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neurotransmitter, the vesicles must be filled before enter-
ing the releasable pool. In this paper, we have demon-
strated that refilling can commence at the earliest
intermediate of the recycling pathway — the stage at
which the recycling vesicle still bears a clathrin coat. It is
widely agreed that uncoating must occur before vesicle
release; we speculate that recycling vesicles may fill with
neurotransmitter before uncoating is complete, and that,
as a consequence, quantal release can be ensured.
Materials and methods
Antibodies
All antibodies and reagents were obtained from Sigma unless otherwise
stated. Monoclonal mouse anti-synaptophysin (S-5768), polyclonal
rabbit anti-mouse (M-9637), polyclonal goat anti-mouse peroxidase con-
jugate (A-4416), and [125I]Protein A (ICN Pharmaceuticals) were used.
Vesicle preparation
Synaptic vesicles were prepared according to the method of Huttner et
al. [5], and their terminology has been adopted. Briefly, synaptosomes
(P2’ fraction) were isolated from brain homogenate. Following lysis of
the synaptosomes by osmotic shock, a series of differential centrifuga-
tion steps were carried out to produce light membrane fractions (first
LS1 and then LP2) enriched in synaptic vesicles. The LP2 pellet was
then loaded onto a linear sucrose gradient which, after spinning for 5 h
at 65 000 g, was harvested as a turbid band in the 0.2–0.4 M sucrose
region (SG-V fraction). The SG-V fraction was diluted in an equal
volume of ice-cold distilled water to reduce the sucrose concentration
to approximately 0.2 M, and then spun at 185 000 g for 2 h at 4°C (TFT
55.38 rotor; Kontron Instruments). The final synaptic-vesicle pellet
(SVP) was resuspended in buffer S (0.32 M sucrose, 10 mM EGTA,
4 mM HEPES–NaOH, pH 7.3) to a final concentration of 2 mg ml–1,
snap frozen and stored at –70°C.
CCVs were prepared from whole rat brain homogenate or isolated rat
synaptosomes as described [2]. Briefly, for whole brain isolated CCVs
(WB CCVs), a light membrane fraction (LM) was produced from brain
homogenate by differential centrifugation steps. The light membranes
were subfractionated using a Ficoll gradient to produce a supernatant
(PFS). Following further differential centrifugation steps to remove sub-
stantial smooth membrane contamination, a supernatant fraction (EF)
enriched in CCVs was produced. EF was layered onto D2O containing
8% sucrose to yield a pellet of highly purified CCVs following centrifu-
gation. For isolation of CCVs from nerve terminals (NT CCVs), the pro-
cedure was essentially the same. Synaptosomes were isolated,
washed to remove contaminating smooth membrane, and ruptured
using osmotic shock. The lysate was adjusted to iso-osmolarity, and
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Figure 3
Mean glutamate uptake in fractions of CCVs and synaptic vesicles.
Normalized to synaptophysin content, the levels of uptake are
comparable for whole brain derived CCVs (WB CCV), nerve terminal
derived CCVs (NT CCV), and a synaptic-vesicle fraction (SVP).
Treatment with 125 nM concanamycin inhibited glutamate uptake to the
control levels seen in the absence of ATP and chloride. For each assay,
either 100 mg WB CCV, 20 mg NT CCV or 10 mg SVP were used;
quantitative analysis indicated that 65mg WB CCV, 30 mg NT CCV
and 10 mg SVP all contained equivalent amounts of synaptophysin (see
Fig. 1b). All incubations were carried out at 30°C for 4 min in the
presence of 0.75% ethanol (see Materials and methods).
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Figure 2
Negative stain of (a) whole brain derived CCV, (b) nerve terminal
derived CCV, and (c) synaptic-vesicle fractions. No coated vesicles
were found in the synaptic-vesicle fraction, and only a low level of
smooth-membrane contamination was present in the coated-vesicle
fractions. The scale bars are 150 nm.
then taken through the same steps as for the brain homogenate in the
WB CCV procedure.
The final WB CCV and NT CCV pellets were resuspended in buffer A
(0.1 M MES–NaOH, pH 6.5, 1 mM EGTA, 0.5 mM MgCl2) to a final
concentration of 3 mg ml–1 (WB CCVs) and 1 mg ml–1 (NT CCVs),
snap frozen and stored at –70°C.
Glutamate uptake assay
The glutamate uptake assay of Naito and Ueda [20] was used. For each
assay, either 100 mg WB CCVs, 20 mg NT CCVs, or 10 mg SVPs, and
2 mCi L-2,3-[3H]glutamate (TRK-445 20–40 Ci mol–1, Amersham) were
used. For concanamycin studies, concanamycin diluted in ethanol was
added to a final concentration of 125 nM, the final ethanol concentration
in all incubation mixtures was 0.75%. Vesicles were equilibrated at 30°C
for 5 min before uptake was initiated by the addition of glutamate
(50 mM), with or without 2 mM ATP and 4 mM KCl. Glutamate uptake
was continued for 4 min at 30°C before it was abolished by the addition
of 2 ml ice-cold 0.15 M KCl; the samples were then vacuum filtered
through 25 mm, 0.45 mm Millipore filters (Whatman, type HA). Following
extensive washing the radioactivity remaining on the filters was counted.
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